These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21147279)

  • 41. Rare disease patient groups as clinical researchers.
    Polich GR
    Drug Discov Today; 2012 Feb; 17(3-4):167-72. PubMed ID: 22016088
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rare diseases - avoiding misperceptions and establishing realities: the need for reliable epidemiological data.
    Groft SC; de la Paz MP
    Adv Exp Med Biol; 2010; 686():3-14. PubMed ID: 20824436
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Rare metabolic diseases].
    Wendel U; Burgard P
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Dec; 50(12):1556-63. PubMed ID: 18026881
    [TBL] [Abstract][Full Text] [Related]  

  • 44. 35 years of Japanese policy on rare diseases.
    Hayashi S; Umeda T
    Lancet; 2008 Sep; 372(9642):889-90. PubMed ID: 18790305
    [No Abstract]   [Full Text] [Related]  

  • 45. [Rare lung diseases].
    Paone G; Toti S; Salvati F
    Recenti Prog Med; 2014 Sep; 105(9):341-50. PubMed ID: 25229763
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The need for worldwide policy and action plans for rare diseases.
    Forman J; Taruscio D; Llera VA; Barrera LA; Coté TR; Edfjäll C; Gavhed D; Haffner ME; Nishimura Y; Posada M; Tambuyzer E; Groft SC; Henter JI;
    Acta Paediatr; 2012 Aug; 101(8):805-7. PubMed ID: 22519914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rare disease patients in China anticipate the sunlight of legislation.
    Gao JJ; Song PP; Tang W
    Drug Discov Ther; 2013 Jun; 7(3):126-8. PubMed ID: 23917862
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Towards efficiency in rare disease research: what is distinctive and important?
    Jia J; Shi T
    Sci China Life Sci; 2017 Jul; 60(7):686-691. PubMed ID: 28639105
    [TBL] [Abstract][Full Text] [Related]  

  • 49. European Reference Networks: Share, Care, and Cure-Future or Dream?
    Wijnen R; Anzelewicz SM; Petersen C; Czauderna P
    Eur J Pediatr Surg; 2017 Oct; 27(5):388-394. PubMed ID: 28977810
    [No Abstract]   [Full Text] [Related]  

  • 50. A call for action to improve access to care and treatment for patients with rare diseases in the Asia-Pacific region.
    Soon SS; Lopes G; Lim HY; Wong-Rieger D; Bahri S; Hickinbotham L; Jha A; Ko BS; MacDonell D; Pwu JR; Shih R; Sirachainan E; Suh DC; Wale J; Zhang X; Wee HL
    Orphanet J Rare Dis; 2014 Sep; 9():137. PubMed ID: 25223275
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Telemedicine strategy of the European Reference Network ITHACA for the diagnosis and management of patients with rare developmental disorders.
    Smith M; Alexander E; Marcinkute R; Dan D; Rawson M; Banka S; Gavin J; Mina H; Hennessy C; Riccardi F; Radio FC; Havlovicova M; Cassina M; Emandi AC; Fradin M; Gompertz L; Nordgren A; Traberg R; Rossi M; Trimouille A; Sowmyalakshmi R; Dallapiccola B; Renieri A; Faivre L; Kerr B; Verloes A; Clayton-Smith J; Douzgou S;
    Orphanet J Rare Dis; 2020 Apr; 15(1):103. PubMed ID: 32334637
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Centres of Expertise and European Reference Networks: key issues in the field of rare diseases. The EUCERD Recommendations.
    Taruscio D; Gentile AE; Evangelista T; Frazzica RG; Bushby K; Montserrat AM
    Blood Transfus; 2014 Apr; 12 Suppl 3(Suppl 3):s621-5. PubMed ID: 24922304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The actual questions of the care of rare diseases].
    Pogány G
    Orv Hetil; 2017 Nov; 158(47):1851-1856. PubMed ID: 29153019
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Patient participation in medical care, taking rare retinal degenerations as examples].
    Brunsmann F; von Gizycki R; Rybalko A; Hildebrandt AG; Rüther K
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Dec; 50(12):1494-501. PubMed ID: 18038106
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Detecting and fighting rare diseases. A necessary expertise].
    Doually Y
    Soins Pediatr Pueric; 2013; (274):13. PubMed ID: 24228327
    [No Abstract]   [Full Text] [Related]  

  • 56. Focus on designing health care structures and services for rare diseases.
    Schultz C; Schreyögg J; Stargardt T; Busse R
    Health Policy; 2012 May; 105(2-3):107-9. PubMed ID: 22469233
    [No Abstract]   [Full Text] [Related]  

  • 57. Medical disorders: Stop marginalizing rare syndromes.
    Kolset SO
    Nature; 2016 Aug; 536(7617):396. PubMed ID: 27558055
    [No Abstract]   [Full Text] [Related]  

  • 58. The countdown for rare disease strategies is underway.
    Lancet Neurol; 2013 Jan; 12(1):1. PubMed ID: 23237886
    [No Abstract]   [Full Text] [Related]  

  • 59. The Undiagnosed Diseases Network International: Five years and more!
    Taruscio D; Baynam G; Cederroth H; Groft SC; Klee EW; Kosaki K; Lasko P; Melegh B; Riess O; Salvatore M; Gahl WA
    Mol Genet Metab; 2020 Apr; 129(4):243-254. PubMed ID: 32033911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Rare diseases as models in clinical research--from genetics to better medical care ].
    Schmidtke J; Schmidt RE
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2007 Dec; 50(12):1475-6. PubMed ID: 18058147
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.